Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
Open Access
- 12 September 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (18) , 9852
Abstract
Selective sodium–glucose cotransporter 2 (SGLT2) inhibitors reduced the risk of hospitalization for heart failure in patients with or without type 2 diabetes (T2DM) in large-scale clinical trials. The exact mechanism of action is currently unclear. The dual SGLT1/2 inhibitor sotagliflozin not only reduced hospitalization for HF in patients with T2DM, but also lowered the risk of myocardial infarction and stroke, suggesting a possible additional benefit related to SGLT1 inhibition. In fact, several preclinical studies suggest that SGLT1 plays an important role in cardiac pathophysiological processes. In this review, our aim is to establish the clinical significance of myocardial SGLT1 inhibition through reviewing basic research studies in the context of SGLT2 inhibitor trials.Keywords
Funding Information
- National Research, Development and Innovation Fund of Hungary (NVKP_16-1–2016-0017)
- Ministry for Innovation and Technology in Hungary (2020-4.1.1.-TKP2020)
- National Research, Development and Innovation Office (NKFIH) of Hungary (K134939)
- New National Excellence Program of the Ministry of Human Capacities of Hungary (ÚNKP-21-3-II-SE-45)
This publication has 84 references indexed in Scilit:
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal TubuleJournal of the American Society of Nephrology, 2011
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family membersDiabetes Therapy, 2010
- SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathyJournal of Molecular and Cellular Cardiology, 2010
- SGLT1 is a novel cardiac glucose transporter that is perturbed in disease statesCardiovascular Research, 2009
- Elevated Cytosolic Na + Decreases Mitochondrial Ca 2+ Uptake During Excitation-Contraction Coupling and Impairs Energetic Adaptation in Cardiac MyocytesCirculation Research, 2006
- Signaling cascade of ANG II-induced inhibition of α-MG uptake in renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2004
- Na+–d-glucose cotransporter in muscle capillaries increases glucose permeabilityBiochemical and Biophysical Research Communications, 2004
- Epidermal growth factor inhibits14C-?-methyl-d-glucopyranoside uptake in renal proximal tubule cells: Involvement of PLC/PKC, p44/42 MAPK, and cPLA2Journal of Cellular Physiology, 2003
- Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)Journal of Cellular Biochemistry, 2003
- The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.Journal of Clinical Investigation, 1994